Log In
Print
BCIQ
Print
Print this Print this
 

GDF-8 inhibitor

  Manage Alerts
Collapse Summary General Information
Company Rigel Pharmaceuticals Inc.
DescriptionGDF-8 inhibitor
Molecular Target Myostatin (GDF8) (MSTN)
Mechanism of ActionMyostatin (GDF-8) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMuscular atrophy
Indication DetailsTreat muscular atrophy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today